The Changing Face of Graft-Versus-Host Disease
Despite advances in the procedure and posttransplantation immunosuppressive therapy, more than half of allogeneic hematopoietic stem cell transplant (HSCT) recipients develop graft-versus-host disease (GVHD), which remains a major cause of morbidity and mortality.
Approach to the Morbilliform Eruption in the Hematopoietic Transplant Patient
The onset of a morbilliform eruption in the posttransplant period presents a diagnostic dilemma. Not only is the morphology nonspecific, but there are also no definitive diagnostic tests that differentiate one etiology from another. In addition, histopathology may be nonspecific.
Emerging Infections in Dermatology
This review will focus on 3 of these emerging infections: community acquired methicillin-resistant Staphylococcus aureus (MRSA), Epstein Barr virus cutaneous infections, and the reemergence of atypical mycobacterial infections.
Severe drug-induced dermatoses
A variety of common dermatoses are known to have
drug-induced variants. This article discusses the clinical
presentation, time frames, reported culprit medications,
pathophysiology and management of drug-induced
lupus, cutaneous vasculitis, pemphigus, pemphigoid,
linear IgA bullous dermatosis, Sweet’s syndrome, erythema
nodosum, pyoderma gangrenosum, pseudolymphoma,
lichen planus, and psoriasis.
The role of dermatopathology in inpatient care
Increasing downward financial pressure and decreasing hospital stay durations make the efficient practice of hospital dermatology and dermatopathology all the more important for patients.